Viatris, Inc. recalls

14 recalls on record · latest: March 17, 2026

Official U.S. recall history for Viatris, Inc., compiled from official government records.

Get recall alerts

Free email alert whenever Viatris, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

Viatris, Inc. recalls Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LL…

March 17, 2026 · Drug & medication recalls Moderate risk Failed Dissolution Specifications

Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC,…

December 23, 2024 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications: Out of specification results obse…

Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, M…

December 23, 2024 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications: Out of specification results obse…

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained

Viatris Inc recalls Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles…

November 18, 2024 · Drug & medication recalls Moderate risk Superpotent Drug and Subpotent Drug: potency failures obtained